Acumen Pharmaceuticals
Stock Forecast, Prediction & Price Target
Acumen Pharmaceuticals Financial Estimates
Acumen Pharmaceuticals Revenue Estimates
Acumen Pharmaceuticals EBITDA Estimates
Acumen Pharmaceuticals Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $26.53M Low: $26.53M High: $26.53M avg. 0% |
Net Income
% change YoY
| $-181.67M N/A | $-40.47M 77.72% | $-52.37M -29.39% | Avg: $-91.21M Low: $-90.41M High: $-53.95M avg. -74.17% | Avg: $-106.78M Low: $-101.59M High: $-63.67M avg. -17.07% | Avg: $-69.02M Low: $-69.02M High: $-69.02M avg. 35.36% | Avg: $-54.92M Low: $-54.92M High: $-54.92M avg. 20.42% |
EBITDA
% change YoY
| $61.57M N/A | $-45.06M -173.18% | $-51.60M -14.50% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $5.30M Low: $5.30M High: $5.30M avg. 0% |
EPS
% change YoY
| -$4.49 N/A | -$1 77.72% | -$1.08 -8.00% | Avg: -$1.45 Low: -$1.86 High: -$1.11 avg. -34.37% | Avg: -$1.73 Low: -$2.09 High: -$1.31 avg. -19.03% | Avg: -$1.42 Low: -$1.42 High: -$1.42 avg. 17.80% | Avg: -$1.13 Low: -$1.13 High: -$1.13 avg. 20.42% |
Operating Expenses
% change YoY
| $19.58M N/A | $45.23M 130.98% | $61.13M 35.15% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $23.80M Low: $23.80M High: $23.80M avg. 0% |
FAQ
What is Acumen Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -8.86% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -90.41M, average is -91.21M and high is -53.95M.
What is Acumen Pharmaceuticals stock revenue growth forecast?
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Acumen Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -3.79% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.86, average is -$1.45 and high is $-1.11.